ArticleFrontiers in oncology2021

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma.

Junjie Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.